EXECUTIVE ENGAGEMENTS
OUTREACH
3707
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
667
Interactions with Platform & by Email
PARTICIPANTS
111
Unique # Participated
VALIDATIONS
32
Responses Validated*
COMPETITORS
69
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
306
PAGES
405
EDITION
16
PRICE
USD $5600
*Engagement stats are ongoing and dynamic
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for ADME-Toxicology Testing estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$10.2 Billion by 2027, growing at a CAGR of 10.1% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$4.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the High Throughput segment is readjusted to a revised 8.1% CAGR for the next 7-year period.
The ADME-Toxicology Testing market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2027 trailing a CAGR of 13.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 8.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.
In the global Molecular Imaging segment, USA, Canada, Japan, China and Europe will drive the 9.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$860.6 Million in the year 2020 will reach a projected size of US$1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.5 Billion by the year 2027, while Latin America will expand at a 11.2% CAGR through the analysis period.
SELECT PLAYERS
ACEA Biosciences Inc.; ADMEcell Inc.; Agilent Technologies, Inc.; Albany Molecular Research Inc.; Beckman Coulter Inc.; CompuDrug International Inc.; Cyprotex PLC.; Dassault Systèmes Biovia Corp.; Eurofins ADME BIOANALYSES SAS; Galapagos NV; Molecular Discovery Ltd.; MultiCASE Inc.; Optivia Biotechnology; PerkinElmer Inc.; Promega Corporation; Simulations Plus Inc.; Takara Bio Europe AB; Tecan Group Ltd.; Thermo Fischer Scientific Inc.
SEGMENTS
» Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology) » Method (Cellular Assay, Biochemical Assay, Ex-vivo, In Silica) » Application (Systemic Toxicity, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| ADME-Tox Testing Gains Traction |
| Recent Market Activity |
| A Peek into the Impact of ADME-Tox Screening on New Drug Discovery |
| Current and Future Analysis |
| US and Europe Dominate, Asia-Pacific Lends Growth Momentum |
| Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge |
| Pharma Industry Renews Focus on Cost Optimization |
| China and India: Hot Spots for R&D Investment |
| ADME-Tox Assays - An Overview |
| Introduction of Early In Vitro ADMET Studies |
| Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis |
| Major Types of Cell-Based HTS Assays for Drug Screening |
| CROs Expand Presence |
| Drug Discovery Outsourcing and Type of Services Outsourced |
| Changing Face of Drug Discovery Outsourcing Activity |
| M&A - Order of the Day |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| ACEA Biosciences, Inc. (USA) |
| ADMEcell, Inc. (USA) |
| Agilent Technologies, Inc. (USA) |
| Albany Molecular Research, Inc. (USA) |
| Beckman Coulter, Inc. (USA) |
| BioreclamationIVT, LLC (USA) |
| Cerep SA (France) |
| CompuDrug International, Inc. (USA) |
| Cyprotex PLC. (UK) |
| CeeTox, Inc. (USA) |
| Dassault Systèmes Biovia Corp. (USA) |
| Eurofins ADME BIOANALYSES SAS (France) |
| Galapagos NV (Belgium) |
| Molecular Discovery Ltd. (UK) |
| MultiCASE, Inc. (USA) |
| Optivia Biotechnology (USA) |
| PerkinElmer, Inc. (USA) |
| Pharmaron, Inc. (USA) |
| Promega Corporation (USA) |
| Qualyst, Inc. (USA) |
| Simulations Plus, Inc. (USA) |
| Taconic Biosciences, Inc. (USA) |
| Takara Bio Europe AB (Sweden) |
| Tecan Group Ltd. (Switzerland) |
| Thermo Fisher Scientific, Inc. (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Current State of ADME-Tox Testing |
| Need for Better Models: A Major Factor Driving Innovation in the Market |
| Focus Shifts to Innovative Approaches |
| In Silico and In Vitro- the Way to Go |
| In Vitro Testing Systems and Its Relevance in Drug Development |
| Growing Inclination towards In-vitro Assays for Toxicology Studies |
| In Silico ADME-Tox Growing at a Fast Clip |
| Advantages of Using In Silico Approaches |
| Factors Hindering Growth |
| 3-D Tissue Bioassays to Enhance In Vitro Toxicity Testing |
| Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing |
| Rising Number of Drug Targets Surge Demand for Cell-Based Assays |
| Growing Focus on the Development of Reproducible and Robust Cell-based Assays |
| Functional Assays: An Effective Way of Predicting Specific Toxic Effects |
| GPCR Targets to Drive Growth in Functional Cell Assay Market |
| New Alternatives for Early-Stage Toxicology Testing |
| Stem Cells Exude Great Potential in Drug Toxicity Testing |
| Primary Hepatocytes Become Standard Tool for Evaluation in Hepatic Metabolism |
| Improved Cryopreservation Technologies Help Expand Use of Hepatocytes |
| Cardiotoxicity Testing Gains Prominence |
| Cell Imaging-Gaining Popularity |
| In Vivo Imaging Persists in ADME-Tox Testing |
| Computational Models on Rise |
| Adoption of Data Management Systems |
| Drug Transporter Analysis Becoming Part of ADME Assessment |
| Slow Metabolism of Novel Drugs Call for More Human Models in Screening |
| Further Advances Required for More Understanding of Biotransformation |
| Introduction of Third Dimension in Cell Culturing Drives Need for New Instrumentation |
| Regulatory Bodies Focus on Transporter Mediated DDIs |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for High Throughput by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for High Throughput by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for High Throughput by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Molecular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for OMICS Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for OMICS Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for OMICS Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cellular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biochemical Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Ex-vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ex-vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ex-vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for In Silica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Systemic Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ADME-Toxicology Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for ADME-Toxicology Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for ADME-Toxicology Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput, Molecular Imaging and OMICS Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput, Molecular Imaging and OMICS Technology for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-vivo and In Silica for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity and Other Applications for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 69 |
Tapping into New Geographical Markets is a Great Way to Grow!
What's Your Addressable Opportunity in the ADME-Toxicology Testing Market?
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com